<DOC>
	<DOCNO>NCT00505960</DOCNO>
	<brief_summary>The purpose study assess feasibility efficacy culturally-tailored , comprehensive behavioral intervention program specially design linguistically challenge ethnic minority immigrant population ( Korean Americans ) type 2 DM .</brief_summary>
	<brief_title>Culturally Tailored Behavioral Diabetes Care Intervention Korean Americans</brief_title>
	<detailed_description>Korean American immigrant ( KAI ) , one underserved understudied minority population U.S. , suffer diabetes , go under-diagnosed , inadequately treat potential result costly tragic consequence . Language barrier , lack self-confidence , diminish social support accompany acculturation process prevent KAI improve health-seeking behavior . Our previous research indicate overwhelming number KAI suffer uncontrolled hyperglycemia also loss self-confidence social isolation language cultural barrier . They urgent need intervention assist effort achieve good glycemic control restore self-confidence diabetes health management able adjust successfully new environment . Therefore , The purpose study assess feasibility efficacy culturally-tailored , comprehensive behavioral intervention program specially design linguistically challenge KAIs type 2 DM . This pilot project test hypothesis : Compared KAI control group , KAI type 2 DM receive comprehensive DM management intervention structure psycho-behavioral education , home glucose monitor telephone transmission system , interaction bilingual nurse case manager show : ( 1 ) great level glucose control ; ( 2 ) great level self-help skill include knowledge relate glucose control , problem-solving skill , heighten confidence mood/affect , adherence treatment recommendation , quality life . An additional outcome measure obtain ideal BP propose intervention focus management multiple risk factor many KA DM patient often struggle .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>Selfidentified first generation Korean American Age 30 year old Resides WashingtonBaltimore area Expresses willingness participate aspect study full course Written consent participate screening/eligibility visit Selfidentified DM HbA1c &gt; = 8 % within 6 month screen Written consent participate clinical trial : agree participate study data collection procedure , receive DM self help education , use HGMT , permit contact medical care provider . Unable give inform consent Physical mental health condition could limit active participation study ( e.g. , blindness eye , severe immobility , psychiatric disease ) Hematological condition would affect A1C assay , e.g. , hemolytic anemia , sickle cell anemia .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2010</verification_date>
</DOC>